Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 980 JPY -0.93%
Market Cap: 444.5B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Kobayashi Pharmaceutical Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kobayashi Pharmaceutical Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Cash & Cash Equivalents
ÂĄ52.1B
CAGR 3-Years
-15%
CAGR 5-Years
-5%
CAGR 10-Years
1%
Shiseido Co Ltd
TSE:4911
Cash & Cash Equivalents
ÂĄ91.9B
CAGR 3-Years
-12%
CAGR 5-Years
-2%
CAGR 10-Years
5%
Rohto Pharmaceutical Co Ltd
TSE:4527
Cash & Cash Equivalents
ÂĄ64.5B
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
13%
Kao Corp
TSE:4452
Cash & Cash Equivalents
ÂĄ304.5B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
14%
Kose Corp
TSE:4922
Cash & Cash Equivalents
ÂĄ116.7B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
12%
F
Fancl Corp
TSE:4921
Cash & Cash Equivalents
ÂĄ33.8B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
7%
No Stocks Found

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
444.5B JPY
Industry
Consumer products

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,451 full-time employees. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

Intrinsic Value
6 896.22 JPY
Undervaluation 13%
Intrinsic Value
Price

See Also

What is Kobayashi Pharmaceutical Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
52.1B JPY

Based on the financial report for Jun 30, 2024, Kobayashi Pharmaceutical Co Ltd's Cash & Cash Equivalents amounts to 52.1B JPY.

What is Kobayashi Pharmaceutical Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
1%

Over the last year, the Cash & Cash Equivalents growth was -43%. The average annual Cash & Cash Equivalents growth rates for Kobayashi Pharmaceutical Co Ltd have been -15% over the past three years , -5% over the past five years , and 1% over the past ten years .

Back to Top